Vimarsana
Biggest News Aggregation in the World

Mari Scheiffele News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mari Scheiffele. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mari Scheiffele Today - Breaking & Trending Today

Capital Markets Day 2023 - Ipsen outlines next phase of growth & transformation and provides new mid-term outlook - Vimarsana News

Capital Markets Day 2023 - Ipsen outlines next phase of growth & transformation and provides new mid-term outlook

PARIS, FRANCE, 7 December 2023 - Ipsen , a global specialty-driven biopharmaceutical company, today holds its Capital Markets Day in London, U.K. “Ipsen has made significant progress since our...

Ipsen : appoints Mari Scheiffele as EVP and President, Specialty Care International -Today at 09:36 am - Vimarsana News

Ipsen : appoints Mari Scheiffele as EVP and President, Specialty Care International -Today at 09:36 am

PARIS, France, 11 October 2021 - Ipsen announced today the appointment of Mari Scheiffele as EVP and President, Specialty Care International, effective November 1st 2021. Based in...

Chutes & Ladders—J&J science chief Stoffels the latest C-suite leader to retire - Vimarsana News

Chutes & Ladders—J&J science chief Stoffels the latest C-suite leader to retire

Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., will retire at the end of the year, following the lead of CEO Alex Gorsky, who also departs soon. Emile Nuwaysir led Bayer's $1 billion bet on Parkinson's disease, and now he heads up gene therapy biotech Ensoma. Genentech's early cancer research leader Shiva Malek jumps to Novartis' NIBR oncology unit.

Ipsen poaches Novartis vet Mari Scheiffele to serve as president of its international specialty care team - Vimarsana News

Ipsen poaches Novartis vet Mari Scheiffele to serve as president of its international specialty care team

Amid its push to grow around the globe in oncology, rare diseases and neuroscience, Ipsen has poached a Novartis veteran to head up its international specialty care team.